In a recent study published in Nature Communications, researchers developed a novel intranasal vaccine candidate, DelNS1-RBD4N-DAF, for coronavirus disease 2019 (COVID-19). This live attenuated ...
When the World Health Organization (WHO) declared COVID-19 to be a global pandemic in March 2020, laboratories and pharmaceutical companies were already developing vaccines, and Oswaldo Cruz ...